Osaic Holdings
QNCX icon

Osaic Holdings’s Quince Therapeutics QNCX Stock Holding History

Osaic Holdings’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55 Sell
3
-1
-25% -$201 ﹤0.01% 7676
2025
Q4 		$2.77K Hold
4
– – ﹤0.01% 6970
2025
Q3 		$1.32K Buy
4
+3
+300% +$999 ﹤0.01% 7262
2025
Q2 		$457 Hold
1
– – ﹤0.01% 7367
2025
Q1 		$368 Sell
1
-3
-75% -$916 ﹤0.01% 7061
2024
Q4 		$1.46K Buy
4
+3
+300% +$901 ﹤0.01% 6726
2024
Q3 		$216 Hold
1
– – ﹤0.01% 7163
2024
Q2 		$207 Hold
1
– – ﹤0.01% 7164
2024
Q1 		$293 Hold
1
– – ﹤0.01% 6907
2023
Q4 		$290 Hold
1
– – ﹤0.01% 6973
2023
Q3 		$310 Hold
1
– – ﹤0.01% 7074
2023
Q2 		$416 Hold
1
– – ﹤0.01% 7091
2023
Q1 		$432 Hold
1
– – ﹤0.01% 7158
2022
Q4 		$0 Hold
1
– – ﹤0.01% 7385
2022
Q3 		$0 Hold
1
– – ﹤0.01% 7458
2022
Q2 		$1K Buy
+1
New +$707 ﹤0.01% 7135
2022
Q1 		– Hold
0
– -$1K – 7441
2021
Q4 		– Sell
-3
Closed -$18.3K – 7230
2021
Q3 		$53K Sell
3
-2
-40% -$31.8K ﹤0.01% 5058
2021
Q2 		$58K Buy
5
+2
+67% +$16.8K ﹤0.01% 4935
2021
Q1 		$18K Buy
+3
New +$21.6K ﹤0.01% 5562
2020
Q2 		– Hold
0
– -$1K – 6282
2020
Q1 		– Hold
0
– – – 5899

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Osaic Holdings's QNCX Position: Q1 2026 in Review

Osaic Holdings reduced its Quince Therapeutics (QNCX) stake by 25% in Q1 2026, selling an estimated $201 and leaving 3 shares worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #7676.

Osaic Holdings first reported a position in QNCX in Q1 2021 and has held it in 19 quarters since. The position peaked at $58K in Q2 2021. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • Osaic Holdings held 3 shares of Quince Therapeutics worth $55 as of Q1 2026.
  • Osaic Holdings sold 1 Quince Therapeutics share in Q1 2026, an estimated $201.
  • Quince Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7676 holding.
  • Osaic Holdings first reported a position in Quince Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • Osaic Holdings's Quince Therapeutics position peaked at $58K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.